Newron Pharmaceuticals (OTCMKTS:NWPHF) Shares Up 119.8% – Here’s Why

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF)’s share price was up 119.8% during mid-day trading on Tuesday . The company traded as high as $20.00 and last traded at $20.00. Approximately 101 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 600 shares. The stock had previously closed at $9.10.

Newron Pharmaceuticals Price Performance

The company has a 50 day simple moving average of $9.57 and a 200 day simple moving average of $9.43.

Newron Pharmaceuticals Company Profile

Newron Pharmaceuticals SpA is a clinical-stage biopharmaceutical company headquartered in Bresso, Italy, dedicated to developing novel therapies for central nervous system (CNS) disorders. The company’s research and development efforts focus on small-molecule compounds designed to address unmet medical needs in neurology and psychiatry.

Newron’s lead product, safinamide, is marketed under the brand name Xadago as an adjunctive therapy for patients with mid- to late-stage Parkinson’s disease.